Registro:

Referencias:

• Abrams, M.B., Dominguez, C., Pernold, K., Reger, R., Wiesenfeld-Hallin, Z., Olson, L., Prockop, D., Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury (2009) Restorative Neurology and Neuroscience, 27, pp. 307-321
• Aggarwal, S., Pittenger, M.F., Human mesenchymal stem cells modulate allogeneic immune cell responses (2005) Blood, 105, pp. 1815-1822
• Alaiti, M.A., Ishikawa, M., Costa, M.A., Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy (2010) Translational Research, 156, pp. 112-129
• Alhadlaq, A., Mao, J.J., Mesenchymal stem cells: isolation and therapeutics (2004) Stem Cells and Development, 13, pp. 436-448
• Alphonso, A., Alahari, S.K., Stromal cells and integrins: conforming to the needs of the tumor microenvironment (2009) Neoplasia (New York, NY), 11, pp. 1264-1271
• Myelofibrosis and the biology of connective tissue (1984) Progress in Clinical and Biological Research, 154, pp. 1-500. , Anonymous
• Aranda, P., Agirre, X., Ballestar, E., Andreu, E.J., Roman-Gomez, J., Prieto, I., Martin-Subero, J.I., Prosper, F., Epigenetic signatures associated with different levels of differentiation potential in human stem cells (2009) PLoS One, 4, pp. e7809
• Baksh, D., Song, L., Tuan, R.S., Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy (2004) Journal of Cellular and Molecular Medicine, 8, pp. 301-316
• Barry, F., Boynton, R., Murphy, M., Haynesworth, S., Zaia, J., The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells (2001) Biochemical and Biophysical Research Communications, 289, pp. 519-524
• Bernardo, M.E., Zaffaroni, N., Novara, F., Cometa, A.M., Avanzini, M.A., Moretta, A., Montagna, D., Locatelli, F., Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms (2007) Cancer Research, 67, pp. 9142-9149
• Bianco, P., Robey, P.G., Saggio, I., Riminucci, M., "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease (2010) Human Gene Therapy, 21, pp. 1057-1066
• Bianco, P., Sacchetti, B., Riminucci, M., Osteoprogenitors and the hematopoietic microenvironment (2011) Best Practice and Research Clinical Haematology, 24, pp. 37-47
• Boiret, N., Rapatel, C., Veyrat-Masson, R., Guillouard, L., Guerin, J.J., Pigeon, P., Descamps, S., Berger, M.G., Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow (2005) Experimental Hematology, 33, pp. 219-225
• Bruno, S., Grange, C., Deregibus, M.C., Calogero, R.A., Saviozzi, S., Collino, F., Morando, L., Camussi, G., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury (2009) Journal of the American Society of Nephrology, 20, pp. 1053-1067
• Buhring, H.J., Battula, V.L., Treml, S., Schewe, B., Kanz, L., Vogel, W., Novel markers for the prospective isolation of human MSC (2007) Annals of the New York Academy of Sciences, 1106, pp. 262-271
• Buhring, H.J., Treml, S., Cerabona, F., de Zwart, P., Kanz, L., Sobiesiak, M., Phenotypic characterization of distinct human bone marrow-derived MSC subsets (2009) Annals of the New York Academy of Sciences, 1176, pp. 124-134
• Caplan, A.I., The mesengenic process (1994) Clinics in Plastic Surgery, 21, pp. 429-435
• Castro-Malaspina, H., Gay, R.E., Resnick, G., Kapoor, N., Meyers, P., Chiarieri, D., McKenzie, S., Moore, M.A., Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny (1980) Blood, 56, pp. 289-301
• Colter, D.C., Class, R., DiGirolamo, C.M., Prockop, D.J., Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow (2000) Proceedings of the National Academy of Sciences of the United States of America, 97, pp. 3213-3218
• Compston, J.E., Bone marrow and bone: a functional unit (2002) The Journal of endocrinology, 173, pp. 387-394
• Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Uccelli, A., Human mesenchymal stem cells modulate B-cell functions (2006) Blood, 107, pp. 367-372
• Chan, J.L., Tang, K.C., Patel, A.P., Bonilla, L.M., Pierobon, N., Ponzio, N.M., Rameshwar, P., Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma (2006) Blood, 107, pp. 4817-4824
• Chang, Y.J., Shih, D.T., Tseng, C.P., Hsieh, T.B., Lee, D.C., Hwang, S.M., Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood (2006) Stem Cells, 24, pp. 679-685
• Charbord, P., Bone marrow mesenchymal stem cells: historical overview and concepts (2010) Human Gene Therapy, 21, pp. 1045-1056
• Chen, L., Zhang, W., Yue, H., Han, Q., Chen, B., Shi, M., Li, J., Zhao, R.C., Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells (2007) Stem Cells and Development, 16, pp. 719-731
• Chopp, M., Li, Y., Zhang, Z.G., Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies (2009) Stroke, 40, pp. S143-145
• De Becker, A., Van Hummelen, P., Bakkus, M., Vande Broek, I., De Wever, J., De Waele, M., Van Riet, I., Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 (2007) Haematologica, 92, pp. 440-449
• Dexter, T.M., Allen, T.D., Lajtha, L.G., Conditions controlling the proliferation of haemopoietic stem cells in vitro (1977) Journal of Cellular Physiology, 91, pp. 335-344
• Dexter, T.M., Wright, E.G., Krizsa, F., Lajtha, L.G., Regulation of haemopoietic stem cell proliferation in long term bone marrow cultures (1977) Biomedicine, 27, pp. 344-349
• Dickhut, A., Schwerdtfeger, R., Kuklick, L., Ritter, M., Thiede, C., Neubauer, A., Brendel, C., Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue (2005) Annals of Hematology, 84, pp. 722-727
• Ding, Y., Xu, D., Feng, G., Bushell, A., Muschel, R.J., Wood, K.J., Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9 (2009) Diabetes, 58, pp. 1797-1806
• Djouad, F., Charbonnier, L.M., Bouffi, C., Louis-Plence, P., Bony, C., Apparailly, F., Cantos, C., Noel, D., Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism (2007) Stem Cells, 25, pp. 2025-2032
• Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D., Jorgensen, C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals (2003) Blood, 102, pp. 3837-3844
• Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Horwitz, E., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement (2006) Cytotherapy, 8, pp. 315-317
• Eaves, C.J., Cashman, J.D., Sutherland, H.J., Otsuka, T., Humphries, R.K., Hogge, D.E., Lansdorp, P.L., Eaves, A.C., Molecular analysis of primitive hematopoietic cell proliferation control mechanisms (1991) Annals of the New York Academy of Sciences, 628, pp. 298-306
• Ezquer, F., Ezquer, M., Simon, V., Pardo, F., Yanez, A., Carpio, D., Conget, P., Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice (2009) Biology of Blood and Marrow Transplantation, 15, pp. 1354-1365
• Fibbe, W.E., Noort, W.A., Mesenchymal stem cells and hematopoietic stem cell transplantation (2003) Annals of the New York Academy of Sciences, 996, pp. 235-244
• Fox, J.M., Chamberlain, G., Ashton, B.A., Middleton, J., Recent advances into the understanding of mesenchymal stem cell trafficking (2007) British Journal of Haematology, 137, pp. 491-502
• Galotto, M., Berisso, G., Delfino, L., Podesta, M., Ottaggio, L., Dallorso, S., Dufour, C., Quarto, R., Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients (1999) Experimental Hematology, 27, pp. 1460-1466
• Gang, E.J., Bosnakovski, D., Figueiredo, C.A., Visser, J.W., Perlingeiro, R.C., SSEA-4 identifies mesenchymal stem cells from bone marrow (2007) Blood, 109, pp. 1743-1751
• Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., Noel, D., Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications (2010) Stem Cell Research and Therapy, 1, p. 2
• Gregory, C.A., Prockop, D.J., Spees, J.L., Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation (2005) Experimental Cell Research, 306, pp. 330-335
• Gregory, C.A., Singh, H., Perry, A.S., Prockop, D.J., The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow (2003) The Journal of Biological Chemistry, 278, pp. 28067-28078
• Gregory, C.A., Ylostalo, J., Prockop, D.J., Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate (2005) Science STKE 294, pp. e37
• Helmy, K.Y., Patel, S.A., Silverio, K., Pliner, L., Rameshwar, P., Stem cells and regenerative medicine: accomplishments to date and future promise (2010) Therapeutic Delivery, 1, pp. 693-705
• Ho, A.D., Wagner, W., Franke, W., Heterogeneity of mesenchymal stromal cell preparations (2008) Cytotherapy, 10, pp. 320-330
• Hofer, E., Chudzinski-Tavassi, A.M., Bullorsky, O.E., Bordenave, R.H., Chasseing, N.A., MMPs and tissue inhibitors in conditioned mediums from bone marrow CFU-F of advanced lung and breast cancer patients (2002) The Hematology Journal, 3, p. 57
• Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A.M., Silberstein, L.E., Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors (2006) Stem Cells, 24, pp. 1030-1041
• Horwitz, E.M., Dominici, M., How do mesenchymal stromal cells exert their therapeutic benefit? (2008) Cytotherapy, 10, pp. 771-774
• Horwitz, E.M., Gordon, P.L., Koo, W.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L., Hofmann, T., Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone (2002) Proceedings of the National Academy of Sciences of the United States of America, 99, pp. 8932-8937
• Jacobsen, K., Kravitz, J., Kincade, P.W., Osmond, D.G., Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice (1996) Blood, 87, pp. 73-82
• Janowska-Wieczorek, A., Majka, M., Ratajczak, J., Ratajczak, M.Z., Autocrine/paracrine mechanisms in human hematopoiesis (2001) Stem Cells, 19, pp. 99-107
• Jiang, X.X., Zhang, Y., Liu, B., Zhang, S.X., Wu, Y., Yu, X.D., Mao, N., Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells (2005) Blood, 105, pp. 4120-4126
• Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Verfaillie, C.M., Pluripotency of mesenchymal stem cells derived from adult marrow (2002) Nature, 418, pp. 41-49
• Jones, E., McGonagle, D., Human bone marrow mesenchymal stem cells in vivo (2008) Rheumatology (Oxford), 47, pp. 126-131
• Karp, J.M., Leng Teo, G.S., Mesenchymal stem cell homing: the devil is in the details (2009) Cell Stem Cell, 4, pp. 206-216
• Kasper, G., Glaeser, J.D., Geissler, S., Ode, A., Tuischer, J., Matziolis, G., Perka, C., Duda, G.N., Matrix metalloprotease activity is an essential link between mechanical stimulus and mesenchymal stem cell behavior (2007) Stem Cells, 25, pp. 1985-1994
• Kasten, P., Beyen, I., Egermann, M., Suda, A.J., Moghaddam, A.A., Zimmermann, G., Luginbuhl, R., Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro (2008) European Cells and Materials, 16, pp. 47-55
• Kidd, S., Spaeth, E., Dembinski, J.L., Dietrich, M., Watson, K., Klopp, A., Battula, V.L., Marini, F.C., Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging (2009) Stem Cells, 27, pp. 2614-2623
• Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., Marini, F.C., The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe (2008) Cytotherapy, 10, pp. 657-667
• Kim, D.H., Yoo, K.H., Choi, K.S., Choi, J., Choi, S.Y., Yang, S.E., Yang, Y.S., Koo, H.H., Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell (2005) Cytokine, 31, pp. 119-126
• Kim, J., Kang, J.W., Park, J.H., Choi, Y., Choi, K.S., Park, K.D., Baek, D.H., Kim, H.S., Biological characterization of long-term cultured human mesenchymal stem cells (2009) Archives of Pharmacal Research, 32, pp. 117-126
• Koc, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynesworth, S.E., Caplan, A.I., Lazarus, H.M., Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy (2000) Journal of Clinical Oncology, 18, pp. 307-316
• Koh, S.H., Noh, M.Y., Cho, G.W., Kim, K.S., Kim, S.H., Erythropoietin increases the motility of human bone marrow-multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs (2009) Stem Cells and Development, 18, pp. 411-421
• Korbling, M., Estrov, Z., Adult stem cells for tissue repair-a new therapeutic concept? (2003) The New England Journal of Medicine, 349, pp. 570-582
• Kortesidis, A., Zannettino, A., Isenmann, S., Shi, S., Lapidot, T., Gronthos, S., Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells (2005) Blood, 105, pp. 3793-3801
• Krause, U., Harter, C., Seckinger, A., Wolf, D., Reinhard, A., Bea, F., Dengler, T., Hansen, A., Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart (2007) Stem Cells and Development, 16, pp. 31-37
• Krebsbach, P.H., Kuznetsov, S.A., Bianco, P., Robey, P.G., Bone marrow stromal cells: characterization and clinical application (1999) Critical Reviews in Oral Biology and Medicine, 10, pp. 165-181
• Kruse, M., Rosorius, O., Kratzer, F., Bevec, D., Kuhnt, C., Steinkasserer, A., Schuler, G., Hauber, J., Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA (2000) The Journal of Experimental Medicine, 191, pp. 1581-1590
• Kuci, S., Kuci, Z., Kreyenberg, H., Deak, E., Putsch, K., Huenecke, S., Amara, C., Bader, P., CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties (2010) Haematologica, 95, pp. 651-659
• La Russa, V.F., Schwarzenberger, P., Miller, A., Agrawal, K., Kolls, J., Weiner, R., Marrow stem cells, mesenchymal progenitor cells, and stromal progeny (2002) Cancer Investigation, 20, pp. 110-123
• Larson, B.L., Ylostalo, J., Prockop, D.J., Human multipotent stromal cells undergo sharp transition from division to development in culture (2008) Stem Cells, 26, pp. 193-201
• Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Ringden, O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study (2008) Lancet, 371, pp. 1579-1586
• Le Blanc, K., Rasmusson, I., Gotherstrom, C., Seidel, C., Sundberg, B., Sundin, M., Rosendahl, K., Ringden, O., Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes (2004) Scandinavian Journal of Immunology, 60, pp. 307-315
• Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., Ringden, O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells (2004) Lancet, 363, pp. 1439-1441
• Le Blanc, K., Ringden, O., Immunomodulation by mesenchymal stem cells and clinical experience (2007) Journal of Internal Medicine, 262, pp. 509-525
• Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S.E., Ringden, O., Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex (2003) Scandinavian Journal of Immunology, 57, pp. 11-20
• Lee, J.W., Fang, X., Gupta, N., Serikov, V., Matthay, M.A., Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung (2009) Proceedings of the National Academy of Sciences of the United States of America, 106, pp. 16357-16362
• Lee, R.H., Oh, J.Y., Choi, H., Bazhanov, N., Therapeutic factors secreted by mesenchymal stromal cells and tissue repair (2011) Journal of Cellular Biochemistry, 112, pp. 3073-3078
• Lee, R.H., Seo, M.J., Reger, R.L., Spees, J.L., Pulin, A.A., Olson, S.D., Prockop, D.J., Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice (2006) Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 17438-17443
• Lepelletier, Y., Lecourt, S., Renand, A., Arnulf, B., Vanneaux, V., Fermand, J.P., Menasche, P., Larghero, J., Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell (2010) Stem Cells and Development, 19, pp. 1075-1079
• Li, H., Guo, Z., Jiang, X., Zhu, H., Li, X., Mao, N., Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease (2008) Stem Cells, 26, pp. 2531-2541
• Li, J., Kwong, D.L., Chan, G.C., The effects of various irradiation doses on the growth and differentiation of marrow-derived human mesenchymal stromal cells (2007) Pediatric Transplantation, 11, pp. 379-387
• Maccario, R., Podesta, M., Moretta, A., Cometa, A., Comoli, P., Montagna, D., Daudt, L., Locatelli, F., Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype (2005) Haematologica, 90, pp. 516-525
• Mackay, A.M., Beck, S.C., Murphy, J.M., Barry, F.P., Chichester, C.O., Pittenger, M.F., Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow (1998) Tissue Engineering, 4, pp. 415-428
• Majumdar, M.K., Thiede, M.A., Mosca, J.D., Moorman, M., Gerson, S.L., Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells (1998) Journal of Cellular Physiology, 176, pp. 57-66
• Matthay, M.A., Advances and challenges in translating stem cell therapies for clinical diseases (2010) Translational Research, 156, pp. 107-111
• Mayani, H., Guilbert, L.J., Janowska-Wieczorek, A., Biology of the hemopoietic microenvironment (1992) European Journal of Haematology, 49, pp. 225-233
• Mendez-Ferrer, S., Michurina, T.V., Ferraro, F., Mazloom, A.R., Macarthur, B.D., Lira, S.A., Scadden, D.T., Frenette, P.S., Mesenchymal and haematopoietic stem cells form a unique bone marrow niche (2010) Nature, 466, pp. 829-834
• Minguell, J.J., Erices, A., Conget, P., Mesenchymal stem cells (2001) Experimental Biology and Medicine (Maywood), 226, pp. 507-520
• Mueller, S.M., Glowacki, J., Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges (2001) Journal of Cellular Biochemistry, 82, pp. 583-590
• Muraglia, A., Corsi, A., Riminucci, M., Mastrogiacomo, M., Cancedda, R., Bianco, P., Quarto, R., Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells (2003) Journal of Cell Science, 116, pp. 2949-2955
• Myers, T.J., Granero-Molto, F., Longobardi, L., Li, T., Yan, Y., Spagnoli, A., Mesenchymal stem cells at the intersection of cell and gene therapy (2010) Expert Opinion on Biological Therapy, 10, pp. 1663-1679
• Nauta, A.J., Fibbe, W.E., Immunomodulatory properties of mesenchymal stromal cells (2007) Blood, 110, pp. 3499-3506
• Nauta, A.J., Kruisselbrink, A.B., Lurvink, E., Willemze, R., Fibbe, W.E., Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells (2006) Journal of Immunology, 177, pp. 2080-2087
• Neuhuber, B., Swanger, S.A., Howard, L., Mackay, A., Fischer, I., Effects of plating density and culture time on bone marrow stromal cell characteristics (2008) Experimental Hematology, 36, pp. 1176-1185
• Ng, F., Boucher, S., Koh, S., Sastry, K.S., Chase, L., Lakshmipathy, U., Choong, C., Tanavde, V., PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages (2008) Blood, 112, pp. 295-307
• Parekkadan, B., Milwid, J.M., Mesenchymal stem cells as therapeutics (2010) Annual Review of Biomedical Engineering, 12, pp. 87-117
• Parekkadan, B., Tilles, A.W., Yarmush, M.L., Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells (2008) Stem Cells, 26, pp. 1913-1919
• Patel, S.A., Sherman, L., Munoz, J., Rameshwar, P., Immunological properties of mesenchymal stem cells and clinical implications (2008) Archivum Immunologiae et Therapiae Experimentalis (Warsz), 56, pp. 1-8
• Pereira, R.F., O'Hara, M.D., Laptev, A.V., Halford, K.W., Pollard, M.D., Class, R., Simon, D., Prockop, D.J., Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta (1998) Proceedings of the National Academy of Sciences of the United States of America, 95, pp. 1142-1147
• Pevsner-Fischer, M., Levin, S., Zipori, D., The origins of mesenchymal stromal cell heterogeneity (2011) Stem Cell Reviews, 7, pp. 560-568
• Ponte, A.L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., Charbord, P., Domenech, J., The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities (2007) Stem Cells, 25, pp. 1737-1745
• Potian, J.A., Aviv, H., Ponzio, N.M., Harrison, J.S., Rameshwar, P., Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens (2003) Journal of Immunology, 171, pp. 3426-3434
• Pountos, I., Giannoudis, P.V., Biology of mesenchymal stem cells (2005) Injury, 36 (SUPPL. 3), pp. S8-S12
• Prindull, G., Hypothesis: cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells? (2005) Experimental Hematology, 33, pp. 738-746
• Prockop, D.J., "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs) (2007) Clinical Pharmacology and Therapeutics, 82, pp. 241-243
• Prockop, D.J., Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms (2009) Molecular Therapy, 17, pp. 939-946
• Prockop, D.J., Defining the probability that a cell therapy will produce a malignancy (2010) Molecular Therapy, 18, pp. 1249-1250
• Prockop, D.J., Brenner, M., Fibbe, W.E., Horwitz, E., Le Blanc, K., Phinney, D.G., Simmons, P.J., Keating, A., Defining the risks of mesenchymal stromal cell therapy (2010) Cytotherapy, 12, pp. 576-578
• Prockop, D.J., Kota, D.J., Bazhanov, N., Reger, R.L., Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs) (2010) Journal of Cellular and Molecular Medicine, 14, pp. 2190-2199
• Rasmusson, I., Le Blanc, K., Sundberg, B., Ringden, O., Mesenchymal stem cells stimulate antibody secretion in human B cells (2007) Scandinavian Journal of Immunology, 65, pp. 336-343
• Ren, G., Su, J., Zhang, L., Zhao, X., Ling, W., L'Huillie, A., Zhang, J., Shi, Y., Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression (2009) Stem Cells, 27, pp. 1954-1962
• Ren, G., Zhao, X., Zhang, L., Zhang, J., L'Huillier, A., Ling, W., Roberts, A.I., Shi, Y., Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression (2010) Journal of Immunology, 184, pp. 2321-2328
• Rougier, F., Dupuis, F., Denizot, Y., Human bone marrow fibroblasts-an overview of their characterization, proliferation and inflammatory mediator production (1996) Hematology and Cell Therapy, 38, pp. 241-246
• Russell, K.C., Phinney, D.G., Lacey, M.R., Barrilleaux, B.L., Meyertholen, K.E., O'Connor, K.C., In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment (2010) Stem Cells, 28, pp. 788-798
• Ruster, B., Gottig, S., Ludwig, R.J., Bistrian, R., Muller, S., Seifried, E., Gille, J., Henschler, R., Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells (2006) Blood, 108, pp. 3938-3944
• Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I., Tagliafico, E., Bianco, P., Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment (2007) Cell, 131, pp. 324-336
• Schmidt, A., Ladage, D., Schinkothe, T., Klausmann, U., Ulrichs, C., Klinz, F.J., Brixius, K., Bloch, W., Basic fibroblast growth factor controls migration in human mesenchymal stem cells (2006) Stem Cells, 24, pp. 1750-1758
• Schwarz, S.C., Schwarz, J., Translation of stem cell therapy for neurological diseases (2010) Translational Research, 156, pp. 155-160
• Sekiya, I., Larson, B.L., Smith, J.R., Pochampally, R., Cui, J.G., Prockop, D.J., Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality (2002) Stem Cells, 20, pp. 530-541
• Shaker, A., Rubin, D.C., Intestinal stem cells and epithelial-mesenchymal interactions in the crypt and stem cell niche (2010) Translational Research, 156, pp. 180-187
• Simmons, P.J., Przepiorka, D., Thomas, E.D., Torok-Storb, B., Host origin of marrow stromal cells following allogeneic bone marrow transplantation (1987) Nature, 328, pp. 429-432
• Sorrentino, A., Ferracin, M., Castelli, G., Biffoni, M., Tomaselli, G., Baiocchi, M., Fatica, A., Valtieri, M., Isolation and characterization of CD146+ multipotent mesenchymal stromal cells (2008) Experimental Hematology, 36, pp. 1035-1046
• Steingen, C., Brenig, F., Baumgartner, L., Schmidt, J., Schmidt, A., Bloch, W., Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells (2008) Journal of Molecular and Cellular Cardiology, 44, pp. 1072-1084
• Sueblinvong, V., Weiss, D.J., Stem cells and cell therapy approaches in lung biology and diseases (2010) Translational Research, 156, pp. 188-205
• Taichman, R.S., Emerson, S.G., The role of osteoblasts in the hematopoietic microenvironment (1998) Stem Cells, 16, pp. 7-15
• Tamama, K., Fan, V.H., Griffith, L.G., Blair, H.C., Wells, A., Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells (2006) Stem Cells, 24, pp. 686-695
• Tocci, A., Forte, L., Mesenchymal stem cell: use and perspectives (2003) The Hematology Journal, 4, pp. 92-96
• Togel, F., Westenfelder, C., Stem cells in acute kidney injury repair (2009) Minerva Urologica e Nefrologica, 61, pp. 205-213
• Tuli, R., Tuli, S., Nandi, S., Huang, X., Manner, P.A., Hozack, W.J., Danielson, K.G., Tuan, R.S., Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk (2003) The Journal of Biological Chemistry, 278, pp. 41227-41236
• Uccelli, A., Prockop, D.J., Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? (2010) Current Opinion in Immunology, 22, pp. 768-774
• Van Overstraeten-Schlogel, N., Beguin, Y., Gothot, A., Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells (2006) European Journal of Haematology, 76, pp. 488-493
• Wagers, A.J., Weissman, I.L., Plasticity of adult stem cells (2004) Cell, 116, pp. 639-648
• Wang, Q.R., Wang, B.H., Zhu, W.B., Huang, Y.H., Li, Y., Yan, Q., An in vitro study of differentiation of hematopoietic cells to endothelial cells (2011) Bone Marrow Research, 2011, pp. 846096-846104
• Wang, R., Stromer, M.H., Huiatt, T.W., Integrin expression in developing smooth muscle cells (1998) The Journal of Histochemistry and Cytochemistry, 46, pp. 119-126
• Waterman, R.S., Tomchuck, S.L., Henkle, S.L., Betancourt, A.M., A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype (2010) PLoS One, 5, pp. e10088
• Whetton, A.D., Dexter, T.M., Influence of growth factors and substrates on differentiation of haemopoietic stem cells (1993) Current Opinion in Cell Biology, 5, pp. 1044-1049
• Wong, R.S., Mesenchymal stem cells: angels or demons? (2011) Journal of Biomedicine and Biotechnology, 2011, pp. 459510-459517
• Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R.G., Kobayashi, N., Yarmush, M.L., Mesenchymal stem cells: mechanisms of immunomodulation and homing (2010) Cell Transplantation, 19, pp. 667-679
• Yamada, M., Suzu, S., Tanaka-Douzono, M., Wakimoto, N., Hatake, K., Hayasawa, H., Motoyoshi, K., Effect of cytokines on the proliferation/differentiation of stroma-initiating cells (2000) Journal of Cellular Physiology, 184, pp. 351-355
• Ylostalo, J., Bazhanov, N., Prockop, D.J., Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies (2008) Experimental Hematology, 36, pp. 1390-1402
• Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Uccelli, A., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy (2005) Blood, 106, pp. 1755-1761
• Zhou, D.H., Huang, S.L., Wu, Y.F., Wei, J., Chen, G.Y., Li, Y., Bao, R., The expansion and biological characteristics of human mesenchymal stem cells (2003) Zhonghua Er Ke Za Zhi, 41, pp. 607-610
• Zipori, D., Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair (2004) Blood Cells, Molecules and Diseases, 33, pp. 211-215
• Zorn, A.M., Wnt signalling: antagonistic Dickkopfs (2001) Current Biology, 11, pp. R592-595

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------